What is shareholder dilution and when is it a good thing?
Nick Sundich, August 3, 2023
With the ASX hosting more small-cap companies than large ones, the concept of shareholder dilution is one that investors should know about.
SIGN UP FOR THE STOCKS DOWN UNDER NEWSLETTER NOW!
What is shareholder dilution?
Shareholder dilution refers to the reduction in the ownership percentage of a company’s shareholders due to the issuance of new shares. This typically happens during capital raisings, where a company sells additional shares to raise funds for purposes such as business expansions, debt repayments, or to fund new projects. While the total number of shares increases, each existing share represents a smaller percentage of the company.
The figure below illustrates a simply example of a private company that brings onboard its first investor. It works similarly for ASX companies raising capital, except it tends to be a smaller share. Companies wishing to raise over 20% of their listed capital need to obtain shareholder approval before raising the money.
Is it worth it? It can be…
Frustrated shareholders may think so when they see the share price decline given that capital is typically raised at a discount to the previous day’s trading price. However, it’s important to note that dilution doesn’t necessarily imply a reduction in the value of individual shares or the overall company. After all, funds raised can potentially increase the overall worth of the company if deployed correctly. And the market cap will remain roughly the same – subject to the share price movement on the day it recommences trading.
What are the Best ASX Stocks to invest in right now?
Check our buy/sell tips on the top Stocks in ASX
It is easy to forget that a company’s IPO is a more major source of dilution than any capital raising once a company has gone public, barring a full recapitalisation of the company. Yet we hardly hear private shareholders grumbling because the capital deployed may help increase the value of their holdings even more.
Consider aspiring PGE developer Chalice (ASX:CHN) – it has raised substantial capital since the initial discovery of the Julimar PGE deposit. $110m at the end of 2020, $100m in 2022 and $70m in 2023. No doubt the share price would be higher if there were the same number of shares on issue as there were in early 2020. But without this further capital, the company may not have been able to grow the deposit to the extent that it has – meaning it would never have reached the heights it has reached today.
But not always…
However, there is a fine line between a company strategically raising capital for growth as opposed to one that is caught in a never-ending cycle of capital raisings and never going anywhere because they’re not deploying it correctly or just a vehicle to fund management’s personal lifestyles.
There have been plenty of examples of the latter on the ASX – both past and present companies. So, when your company raises capital and you experience dilution, it is important to see how the capital is proposed to be deployed and judge for yourself whether or not you trust the management to execute to the plan and that it will create shareholder value.
If you do, then stick with your shareholding and cop the dilution – but by all means keep an eye on the company and how it is faring. If you don’t, and you fear a never-ending cycle of dilution, then it is time to exit and either take profits or a tax loss. The latter is a lesser evil than losing all your money if a company enters administration.
Stocks Down Under Concierge is here to help you pick winning stocks!
The team at Stocks Down Under have been in the markets since the mid-90s and we have gone through many ups and downs. We have written about every sector!
Our Concierge BUY and SELL service picks the best stocks on ASX. We won’t just tell you what to buy – we give you a buy range, price target and stop loss level in order to maximise total returns. And we will only recommend very high conviction stocks where substantial due diligence has been conducted.
Our performance is well ahead of the ASX200 and All Ords.
You can try out Concierge … for FREE.
GET A FREE TRIAL TO CONCIERGE TODAY
There’s no credit card needed – the trial expires automatically.
Blog Categories
Get Our Top 5 ASX Stocks for FY25
Recent Posts
Paradigm Biopharmaceuticals (ASX:PAR): An osteoarthritis solution that could hit the market within 3 years
If you thought the were plenty of treatments for osteoarthritis already, Paradigm Biopharmaceuticals (ASX:PAR) is a company that has something…
Cann Group (ASX:CAN): Successfully producing GMP medicinal cannabis since 2017
Cann Group (ASX:CAN) is the first company in Australia that was issued a medicinal cannabis license, granted by the Australian…
CET1 ratio: If you invest in ASX bank stocks, here’s why it is an important metric to know
In this article we look at the Common Equity Tier 1 (CET1) ratio – what it is and why it…